Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09ZMV
|
|||
| Former ID |
DIB010998
|
|||
| Drug Name |
Votucalis
|
|||
| Synonyms |
EV-131; REV-131; Tick-derived compounds, Evolutec; Votucalis (intranasal), Evolutec; Votucalis (ophthalmic), Evolutec; Votucalis (respiratory disease), Evolutec; REV-131 (intranasal), Evolutec; REV-131 (ophthalmic), Evolutec; REV-131 (respiratory disease), Evolutec
Click to Show/Hide
|
|||
| Indication | Allergic rhinitis [ICD-11: CA08.0] | Phase 2 | [1] | |
| Company |
Evolutec Group plc; Evolutec
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine receptor (HR) | Target Info | Antagonist | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00353964) Safety and Efficacy Study of rEV131 in the Treatment of Ocular Inflammation After Cataract Surgery. U.S. National Institutes of Health. | |||
| REF 2 | CA patent application no. 520580, Histamine binding compounds for treatment method for disease conditions mediated by neutrophils. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.